Skip to main content

Research Repository

Advanced Search

EARLY DIAPAC: EARLY DIAgnosis of PAncreatic Cancer by combined proteomics and genomics testing of pancreatic cyst fluid.

Project Image

People Involved

Project Description

This is part of a total project cost of £98,508.70.

Project Acronym EARLY DIAPAC
Status Project Live
Funder(s) CRUK Cancer Research UK
Value £72,818.00
Project Dates Dec 1, 2022 - Dec 31, 2024
Partner Organisations Hull University Teaching Hospitals NHS Trust

You might also like

Can prevention of the activation of PAR2 prevent the release of procoagulant microvesicles from cancer cells, reduce the risk of VTE and contain the deterioration of the vasculature? Jul 1, 2015 - Jun 30, 2020
The study aims to demonstrate the indirect effect of Apixaban on suppressing the release of pro-inflammatory, pro-coagulant tissue factor-containing microvesicles, by inhibiting factor Xa and preventing the activation of PAR2. The study also demonstr... Read More about Can prevention of the activation of PAR2 prevent the release of procoagulant microvesicles from cancer cells, reduce the risk of VTE and contain the deterioration of the vasculature?.

Development of fully humanised animal free models to study the role of endothelial cells in chronic diseases. Jul 2, 2018 - Aug 28, 2018
Endothelial cells play important roles within the human body. They line blood and lymphatic vessels and regulate the work of cardiovascular and lymphatic systems. The faulty function of endothelial cells often contributes to the development of life-t... Read More about Development of fully humanised animal free models to study the role of endothelial cells in chronic diseases..